JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2576
Peloton Interactive
PTON
$2.14B
| $3.69M | ﹤0.01% |
63,946
-435,989
| -87% | -$18M |
2019 Q3
3 quarters
|
|
2577
Smith & Wesson
SWBI
$651M
| $3.68M | ﹤0.01% |
222,640
-67,803
| -23% | -$630K |
2015 Q4
18 quarters
|
|
|
TBRG
2578
DELISTED
TruBridge
TBRG
| $3.68M | ﹤0.01% |
161,404
-7,285
| -4% | -$163K |
2016 Q3
15 quarters
|
|
2579
O-I Glass
OI
$884M
| $3.68M | ﹤0.01% |
409,392
+159,622
| +64% | +$1.23M |
2013 Q2
28 quarters
|
|
2580
CALL
Zoom
ZM
$27.5B
| $3.68M | ﹤0.01% |
14,500
-15,500
| -52% | -$2.79M |
2019 Q4
2 quarters
|
|
2581
Plexus
PLXS
$7.27B
| $3.67M | ﹤0.01% |
52,045
+24,016
| +86% | +$1.49M |
2015 Q3
19 quarters
|
|
2582
PUT
Broadcom
AVGO
$1.79T
| $3.66M | ﹤0.01% |
116,000
-426,000
| -79% | -$11.9M |
2018 Q1
9 quarters
|
|
2583
OraSure Technologies
OSUR
$260M
| $3.66M | ﹤0.01% |
314,784
-21,226
| -6% | -$276K |
2015 Q4
18 quarters
|
|
2584
Enpro
NPO
$7.03B
| $3.66M | ﹤0.01% |
74,165
-1,283
| -2% | -$56.7K |
2015 Q4
18 quarters
|
|
|
MRTX
2585
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.65M | ﹤0.01% |
32,000
-90,000
| -74% | -$8.73M |
2019 Q4
2 quarters
|
|
2586
CALL
Bath & Body Works
BBWI
$3.62B
| $3.64M | ﹤0.01% |
+301,086
| New | +$3.36M |
2020 Q2
0 quarters
|
|
2587
Apyx Medical
APYX
$107M
| $3.64M | ﹤0.01% |
655,522
+537,084
| +453% | +$2.23M |
2018 Q1
9 quarters
|
|
|
NXRT
2588
NexPoint Residential Trust
NXRT
$516M
| $3.63M | ﹤0.01% |
102,791
+18,315
| +22% | +$567K |
2015 Q4
18 quarters
|
|
2589
Assembly Biosciences
ASMB
$452M
| $3.63M | ﹤0.01% |
12,962
-6,382
| -33% | -$1.49M |
2017 Q2
12 quarters
|
|
2590
Rocket Pharmaceuticals
RCKT
$272M
| $3.62M | ﹤0.01% |
172,817
+7,802
| +5% | +$141K |
2018 Q2
8 quarters
|
|
2591
ATN International
ATNI
$437M
| $3.61M | ﹤0.01% |
59,630
+35,108
| +143% | +$2.11M |
2016 Q2
16 quarters
|
|
2592
Mitek Systems
MITK
$788M
| $3.6M | ﹤0.01% |
375,166
+199,142
| +113% | +$1.8M |
2017 Q3
11 quarters
|
|
2593
PUT
PagSeguro Digital
PAGS
$2.95B
| $3.6M | ﹤0.01% |
+102,000
| New | +$2.87M |
2020 Q2
0 quarters
|
|
2594
Hess Midstream
HESM
$4.97B
| $3.6M | ﹤0.01% |
196,566
-217,791
| -53% | -$3.63M |
2017 Q2
12 quarters
|
|
2595
PUT
Abbott
ABT
$170B
| $3.59M | ﹤0.01% |
39,300
-41,600
| -51% | -$3.76M |
2017 Q3
11 quarters
|
|
|
PRO
2596
DELISTED
PROS Holdings
PRO
| $3.59M | ﹤0.01% |
80,735
-19,354
| -19% | -$683K |
2017 Q3
11 quarters
|
|
2597
Kosmos Energy
KOS
$1.55B
| $3.58M | ﹤0.01% |
2,159,456
+1,766,965
| +450% | +$2.84M |
2013 Q2
28 quarters
|
|
2598
PUT
Verizon
VZ
$191B
| $3.58M | ﹤0.01% |
65,000
+10,100
| +18% | +$568K |
2014 Q2
24 quarters
|
|
2599
TG Therapeutics
TGTX
$7.99B
| $3.58M | ﹤0.01% |
183,643
-20,929
| -10% | -$337K |
2016 Q4
14 quarters
|
|
|
NXGN
2600
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $3.58M | ﹤0.01% |
325,709
+238,537
| +274% | +$2.47M |
2016 Q4
14 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.